Clinical significance and implications of genetic and genomic studies in patients with osteoarthritis

References

• Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115–2126.
   PubMed Web of Science ®Google Scholar
• Guccione AA, Felson DT, Anderson JJ, et al: The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84(3):351–358.
   PubMed Web of Science ®Google Scholar
• DeFrances CJ, Podgornik MN. 2004 National Hospital Discharge Survey. Adv Data. 2006;(371):1–19.
   Google Scholar
• Yelin E. The economics of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, editors. Osteoarthritis. New York: Oxford University Press; 1998. p. 23–30.
   Google Scholar
• Li Y, Wei X, Zhou J, Wei L. The age-related changes in cartilage and osteoarthritis. Biomed Res Int. 2013;2013:916530.
   PubMed Web of Science ®Google Scholar
• Lawrence RC, Felson DT, Helmick CG, et al: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26–35.
   PubMed Web of Science ®Google Scholar
• Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133(8):635–646.
   PubMed Web of Science ®Google Scholar
• Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty S. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res. 2001;(Suppl 391):S26–S33.
   Google Scholar
• Burr DB. The importance of subchondral bone in osteoarthrosis. Curr Opin Rheumatol. 1998;10(3):256–262.
   Google Scholar
• Lajeunesse D. Altered subchondral osteoblast cellular metabolism in osteoarthritis: cytokines, eicosanoids, and growth factors. J Musculoskelet Neuronal Interact. 2002;2(6):504–506.
   Google Scholar
• Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005;365(9463):965–973.
   PubMed Web of Science ®Google Scholar
• Poole AR. Cartilage in health and disease. In: Koopman W, editor. Arthritis and Allied Conditions. A Textbook of Rheumatology. 14th ed. New York: Lippincott Williams and Wilkins; 2001. p. 2260–2284.
   Google Scholar
• Roughley PJ. Age-associated changes in cartilage matrix: implications for tissue repair. Clin Orthop Relat Res. 2001;(Suppl 391):S153–S160.
   Google Scholar
• Chapman K, Valdes AM. Genetic factors in OA pathogenesis. Bone. 2012;51(2):258–264.
   Web of Science ®Google Scholar
• Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet. 1990;46(2):222–228.
   PubMed Web of Science ®Google Scholar
• Guo SW. Sibling recurrence risk ratio as a measure of genetic effect: caveat emptor! Am J Hum Genet. 2002;70(3):818–819.
   Google Scholar
• Botha-Scheepers SA, Watt I, Slagboom E, et al. Influence of familial factors on radiologic disease progression over two years in siblings with osteoarthritis at multiple sites: a prospective longitudinal cohort study. Arthritis Rheum. 2007;57(4):626–632.
   Google Scholar
• MacGregor AJ, Antoniades L, Matson M, Andrew T, Spector TD. The genetic contribution to radiographic hip osteoarthritis in women: results of a classic twin study. Arthritis Rheum. 2000;43(11):2410–2416.
   PubMedGoogle Scholar
• Reynard LN, Loughlin J. The genetics and functional analysis of primary osteoarthritis susceptibility. Expert Rev Mol Med. 2013;15:e2.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Demissie S, Cupples LA, Aliabadi P, Felson DT. A genome scan for joint-specific hand osteoarthritis susceptibility: The Framingham Study. Arthritis Rheum. 2004;50(8):2489–2496.
   Google Scholar
• Chapman K, Mustafa Z, Irven C, et al. Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage. Am J Hum Genet. 1999;65(1):167–174.
   Web of Science ®Google Scholar
• Loughlin J, Mustafa Z, Irven C, et al. Stratification analysis of an osteoarthritis genome screen-suggestive linkage to chromosomes 4, 6, and 16. Am J Hum Genet. 1999;65(6):1795–1798.
   PubMed Web of Science ®Google Scholar
• Livshits G, Kato BS, Zhai G, et al. Genomewide linkage scan of hand osteoarthritis in female twin pairs showing replication of quantitative trait loci on chromosomes 2 and 19. Ann Rheum Dis. 2007;66(5):623–627.
   Web of Science ®Google Scholar
• Stefansson SE, Jonsson H, Ingvarsson T, et al. Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3. Am J Hum Genet. 2003;72(6):1448–1459.
   Web of Science ®Google Scholar
• Ingvarsson T, Stefansson SE, Gulcher JR, et al. A large Icelandic family with early osteoarthritis of the hip associated with a susceptibility locus on chromosome 16p. Arthritis Rheum. 2001;44(11):2548–2555.
   Google Scholar
• Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. Osteoarthritis susceptibility loci defined by genome scan meta-analysis. Rheumatol Int. 2006;26(11):996–1000.
   Google Scholar
• Eyre DR. The collagens of articular cartilage. Semin Arthritis Rheum. 1991;21(3 Suppl 2):2–11.
   PubMed Web of Science ®Google Scholar
• Eyre DR, Weis MA, Moskowitz RW. Cartilage expression of a type II collagen mutation in an inherited form of osteoarthritis associated with a mild chondrodysplasia. J Clin Invest. 1991;87(1):357–361.
   PubMed Web of Science ®Google Scholar
• Pun YL, Moskowitz RW, Lie S, et al. Clinical correlations of osteoarthritis associated with a single-base mutation (arginine 519 to cysteine) in type II procollagen gene. A newly defined pathogenesis. Arthritis Rheum. 1994;37(2):264–269.
   Google Scholar
• Byers PH. Folding defects in fibrillar collagens. Philos Trans R Soc Lond B Biol Sci. 2001;356(1406):157–158.
   Web of Science ®Google Scholar
• Rodriguez RR, Seegmiller RE, Stark MR, Bridgewater LC. A type XI collagen mutation leads to increased degradation of type II collagen in articular cartilage. Osteoarthritis Cartilage. 2004;12(4):314–320.
   Web of Science ®Google Scholar
• Wu JJ, Woods PE, Eyre DR. Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. J Biol Chem. 1992;267(32):23007–23014.
   Web of Science ®Google Scholar
• Näkki A, Videman T, Kujala UM, et al. Candidate gene association study of magnetic resonance imaging-based hip osteoarthritis (OA): evidence for COL9A2 gene as a common predisposing factor for hip OA and lumbar disc degeneration. J Rheumatol. 2011;38(4):747–752.
   Web of Science ®Google Scholar
• Jackson GC, Marcus-Soekarman D, Stolte-Dijkstra I, Verrips A, Taylor JA, Briggs MD. Type IX collagen gene mutations can result in multiple epiphyseal dysplasia that is associated with osteochondritis dissecans and a mild myopathy. Am J Med Genet A. 2010;152A(4):863–869.
   PubMed Web of Science ®Google Scholar
• Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25(11):2203–2212.
   PubMed Web of Science ®Google Scholar
• Pratta MA, Yao W, Decicco C, et al. Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem. 2003;278(46):45539–45545.
   Google Scholar
• Stattin EL, Wiklund F, Lindblom K, et al. A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. Am J Hum Genet. 2010;86(2):126–137.
   Web of Science ®Google Scholar
• Jayasuriya CT, Chen Q. Cartilage extracellular matrix integrity and OA, In: Rothschild BM, editor. Principles of osteoarthritis – Its definition, character, derivation and modality-related recognition [Internet]. InTech; 2012. Available from: http://www.intechopen.com/books/principles-of-osteoarthritis-its-definition-character-derivation-and-modality-related-recognition/cartilage-extracellular-matrix-integrity-and-oa.
   Google Scholar
• Lorenzo P, Aspberg A, Onnerfjord P, Bayliss MT, Neame PJ, Heinegard D. Identification and characterization of asporin. A novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J Biol Chem. 2001;276(15):12201–12211.
   Web of Science ®Google Scholar
• Nakajima M, Kizawa H, Saitoh M, Kou I, Miyazono K, Ikegawa S. Mechanisms for asporin function and regulation in articular cartilage. J Biol Chem. 2007;282(44):32185–32192.
   Web of Science ®Google Scholar
• Hecht JT, Hayes E, Haynes R, Cole WG. COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol. 2005;23(8):525–533.
   Web of Science ®Google Scholar
• Posey KL, Hecht JT. The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets. 2008;9(10):869–877.
   Web of Science ®Google Scholar
• Mu SC, Lin YJ, Liu HC, et al. A mutation in cartilage oligomeric matrix protein (COMP) causes early-onset osteoarthritis in a large kindred study. Ann Hum Genet. 2011;75(5):575–583.
   Google Scholar
• Mabuchi A, Ikeda T, Fukuda A, et al. Identification of sequence polymorphisms of the COMP (cartilage oligomeric matrix protein) gene and association study in osteoarthrosis of the knee and hip. J Hum Genet. 2001;46(8):456–462.
   Web of Science ®Google Scholar
• Klatt AR, Becker AK, Neascu CD, Paulsson M, Weganer R. The matrilins: modulators of extracellular matrix assembly. Int J Biochem Cell Biol. 2011;43(3):320–330.
   Web of Science ®Google Scholar
• Otten C, Hansen U, Talke A, Weganer R, Paulsson M, Zaucke F. A matrilin-3 mutation associated with osteoarthritis does affect collagen affinity but promotes the formation of wider cartilage collagen fibrils. Hum Mutat. 2010;31(3):254–263.
   Web of Science ®Google Scholar
• Min JL, Meulenbelt I, Riyazi N, et al. Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand. Ann Rheum Dis. 2006;65(8):1060–1066.
   Web of Science ®Google Scholar
• Gu J, Rong J, Guan F, et al. MATN3 gene polymorphism is associated with osteoarthritis in Chinese Han population: a community-based case-control study. ScientificWorldJournal. 2012;2012:656084.
   Google Scholar
• van der Weyden L, Wei L, Luo J, et al. Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis. Am J Pathol. 2006;169(2):515–527.
   Web of Science ®Google Scholar
• Waller KA, Zhang LX, Elsaid KA, Fleming BC, Warman ML, Jay GD. Role of lubricin and boundary lubrication in the prevention of chondrocyte apoptosis. Proc Natl Acad Sci U S A. 2013;110(15):5852–5857.
   PubMed Web of Science ®Google Scholar
• Bao JP, Chen WP, Wu LD. Lubricin: a novel potential biotherapeutic approaches for the treatment of osteoarthritis. Mol Biol Rep. 2011;38(5):2879–2885.
   Web of Science ®Google Scholar
• Hochberg MC, Yerges-Armstrong L, Yau M, Mitchell BD. Genetic epidemiology of osteoarthritis: recent developments and future directions. Curr Opin Rheumatol. 2013;25(2):192–197.
   Web of Science ®Google Scholar
• Valdes AM, Evangelou E, Kerkhof HJ, et al. The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann Rheum Dis. 2011;70(5):873–875.
   PubMed Web of Science ®Google Scholar
• Evangelou E, Valdes AM, Kerkhof HJ, et al. Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis. 2011;70(2):349–355.
   Web of Science ®Google Scholar
• Day-Williams AG, Southam L, Panoutsopoulou K, et al. A variant in MCF2L is associated with osteoarthritis. Am J Hum Genet. 2011; 89(3):446–450.
   Web of Science ®Google Scholar
• arcOGEN Consortium; arcOGEN Collaborators. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet. 2012;380(9844):815–823.
   Web of Science ®Google Scholar
• Panoutsopoulou K, Southam L, Elliott KS, et al. Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis. 2011;70(5):864–867.
   Web of Science ®Google Scholar
• Loughlin J. Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting. Curr Opin Rheumatol. 2005;17(5):629–633.
   Web of Science ®Google Scholar
• Mototani H, Mabuchi A, Saito S, et al. A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese. Hum Mol Genet. 2005;14(8):1009–1017.
   PubMed Web of Science ®Google Scholar
• Ikegawa S. New gene associations in osteoarthritis: what do they provide, and where are we going? Curr Opin Rheumatol. 2007;19(5):429–434.
   Google Scholar
• Dai J, Ikegawa S. Recent advances in association studies of osteoarthritis susceptibility genes. J Hum Genet. 2010;55(2):77–80.
   Web of Science ®Google Scholar
• Cornelis FM, Luyten FP, Lories RJ. Functional effects of susceptibility genes in osteoarthritis. Discov Med. 2011;12(63):129–139.
   Web of Science ®Google Scholar
• Bos SD, Slagboom PE, Meulenbelt I. New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr Opin Rheumatol. 2008;20(5):553–559.
   Web of Science ®Google Scholar
• Valdes AM, Van Oene M, Hart DJ, et al. Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis Rheum. 2006;54(2):533–539.
   PubMed Web of Science ®Google Scholar
• Loughlin J, Sinsheimer JS, Carr A, Chapman K. The CALM1 core promoter polymorphism is not associated with hip osteoarthritis in a United Kingdom Caucasian population. Osteoarthritis Cartilage. 2006;14(3):295–298.
   Web of Science ®Google Scholar
• Shi D, Ni H, Dai J, et al. Lack of association between the CALM1 core promoter polymorphism (-16C/T) and susceptibility to knee osteoarthritis in a Chinese Han population. BMC Med Genet. 2008;9:91.
   Web of Science ®Google Scholar
• Poulou M, Kaliakatsos M, Tsezou A, Kanavakis E, Malizos KN, Tzetis M. Association of the CALM1 core promoter polymorphism with knee osteoarthritis in patients of Greek origin. Genet Test. 2008;12(2):263–265.
   Google Scholar
• Shin MH, Lee SJ, Kee SJ, et al. Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis. Joint Bone Spine. 2012;79(5):488–491.
   Web of Science ®Google Scholar
• Chen X, Zankl A, Niroomand F, et al. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J Mol Cell Cardiol. 2006;41(1):26–33.
   Web of Science ®Google Scholar
• Liu Z, Shen J, Pu K, et al. GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP. Biochim Biophys Acta. 2009;1793(12):1819–1827.
   PubMed Web of Science ®Google Scholar
• Lewis AC, Malemud CJ. Correction of dysfunctional apoptosis in arthritis by pharmacologic interventions: Focus on altering the activity of inhibitor of apoptosis protein. In: Pandalai SG, editor. Recent Research Developments in Pharmacology. Kerala: Research Signpost; 2011. p. 69–84.
   Google Scholar
• Zaidi SH, Huang Q, Momen A, Riazi A, Husain M. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction. J Am Coll Cardiol. 2010;55(2):135–143.
   Web of Science ®Google Scholar
• Ratnayake M, Plöger F, Santibanez-Koref M, Loughlin J. Human chondrocytes respond discordantly to the protein encoded by the osteoarthritis susceptibility gene GDF5. PLoS One. 2014;9(1):e86590.
   Web of Science ®Google Scholar
• Dodd AW, Rodriguez-Fontenia C, Calaza M, et al. Deep sequencing of GDF5 reveals the absence of rare variants at this important osteoarthritis susceptibility locus. Osteoarthritis Cartilage. 2011;19(4):430–434.
   Web of Science ®Google Scholar
• Malemud CJ, Stevenson S, Mehraban F, Papay RS, Purchio AF, Goldberg VM. The proteoglycan synthesis repertoire of rabbit chondrocytes maintained in Type II collagen gels. Osteoarthritis Cartilage. 1994;2(1):29–42.
   Google Scholar
• Enochson L, Stenberg J, Brittberg M, Lindahl A. GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition. Osteoarthritis Cartilage. 2014;22(4):566–577.
   Web of Science ®Google Scholar
• Miyaki S, Nakasa T, Otsuki S, et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009;60(9):2723–2730.
   PubMed Web of Science ®Google Scholar
• Swingler TE, Wheeler G, Carmont V, et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum. 2012;64(6):1909–1919.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jia J, Yang S, Liu X, Ye S, Tian H. MicroRNA-21 controls the development of osteoarthritis by targeting GDF-5 in chondrocytes. Exp Mol Med. 2014;46:e79.
   PubMed Web of Science ®Google Scholar
• Malemud CJ. Repair of injury to articular cartilage with chondrocyte progenitor cells. Rheumatol Curr Res. 2013;3(2):122.
   Google Scholar
• Cheng X, Yang T, Meng W, Liu H, Zhang T, Shi R. Overexpression of GDF5 through an adenovirus vector stimulates osteogenesis of human mesenchymal stem cells in vitro and in vivo. Cells Tissues Organs. 2012;196(1):56–67.
   Web of Science ®Google Scholar
• Jin L, Li X. Growth differentiation factor 5 regulation in bone regeneration. Curr Pharm Des. 2013;19(19):3364–3373.
   Web of Science ®Google Scholar
• Daans M, Luyten FP, Lories RJ. GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis. 2011;70(1):208–213.
   Web of Science ®Google Scholar
• Ikegawa S. The genetics of common degenerative skeletal disorders: osteoarthritis and degenerative disc disease. Annu Rev Genomics Hum Genet. 2013;14:245–256.
   Web of Science ®Google Scholar
• Miyamoto Y, Mabuchi A, Shi D, et al. A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet. 2007;39(4):529–533.
   Web of Science ®Google Scholar
• Evangelou E, Chapman K, Meulenbelt I, et al. Large-scale analysis of the association between GDF5 and FRZB variants and osteoarthritis of the hip, knee and hand. Arthritis Rheum. 2009;60(6):1710–1721.
   Google Scholar
• Egli RJ, Southam L, Wilkins JM, et al. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum. 2009;60(7):2055–2064.
   Google Scholar
• Dodd AW, Syddall CM, Loughlin J. A rare variant in the osteoarthritis-associated locus GDF5 is functional and reveals a site that can be manipulated to modulate GDF5 expression. Eur J Hum Genet. 2013;21(5):517–521.
   Web of Science ®Google Scholar
• Reynard LN, Bui C, Canty-Laird EG, Young DA, Loughlin J. Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet. 2011;20(17):3450–3460.
   Web of Science ®Google Scholar
• Valdes AM, Spector TD, Doherty S, Wheeler M, Hart DJ, Doherty M. Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations. Ann Rheum Dis. 2009;68(12):1916–1920.
   Web of Science ®Google Scholar
• Hao SW, Jin QH. Association between the +104T/C polymorphism in the 5′ UTR of GDF5 and susceptibility to knee osteoarthritis: a meta-analysis. Mol Med Rep. 2013;7(2):485–488.
   Web of Science ®Google Scholar
• Tsezou A, Satra M, Oikonomou P, Bargiotas K, Malizos KN. The growth differentiation factor 5 (GDF-5) core promoter polymorphism is not associated with knee osteoarthritis in the Greek population. J Orthop Res. 2008;26(1):136–140.
   Web of Science ®Google Scholar
• Tawonsawatruk T, Changthong T, Pingsuthiwong S, Trachoo O, Sura T, Wajanavisit W. A genetic association study between growth differentiation factor 5 (GDF5) polymorphism and knee osteoarthritis in Thai population. J Orthop Surg Res. 2011;6:47.
   Web of Science ®Google Scholar
• Logan CW, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810.
   PubMed Web of Science ®Google Scholar
• Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis. 2008;4(2):68–75.
   PubMedGoogle Scholar
• Nusse R, Varmus H. Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 2012;31(12):2670–2684.
   PubMed Web of Science ®Google Scholar
• Habas R, Dawid IB. Dishevelled and Wnt signaling: is the nucleus the final frontier? J Biol. 2005;4(1):2.
   Google Scholar
• Schett G, Zwerina J, David JP. The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol. 2008;4(9):473–480.
   PubMedGoogle Scholar
• Wang M, Shen J, Jin H, Im HJ, Sandy J, Chen D. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann N Y Acad Sci. 2011;1240:61–69.
   PubMed Web of Science ®Google Scholar
• Blom AB, Brockbank SM, van Lent PL, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein-1. Arthritis Rheum. 2009;60(2):501–512.
   PubMed Web of Science ®Google Scholar
• Pulsatelli L, Addimanda O, Brusi V, Pavloska B, Meliconi R. New findings in osteoarthritis pathogenesis: therapeutic implications. Ther Adv Chronic Dis. 2013;4(1):23–43.
   Google Scholar
• Nalesso G, Sherwood J, Bertrand J, et al. WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways. J Cell Biol. 2011;193(3):551–564.
   PubMed Web of Science ®Google Scholar
• Zhu M, Chen M, Zuscik M, et al. Inhibition of β-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum. 2008;58(7):2053–2064.
   PubMedGoogle Scholar
• Schroeppel JP, Crist JD, Anderson HC, Wang J. Molecular recognition of articular chondrocyte function and its significance in osteoarthritis. Histol Histopathol. 2011;26(3):377–394.
   PubMed Web of Science ®Google Scholar
• Pasold J, Osterberg A, Peters K, et al. Reduced expression of Sfrp1 during chondrogenesis and in articular chondrocytes correlates with osteoarthritis in STR/ort mice. Exp Cell Res. 2013;319(5):649–659.
   Web of Science ®Google Scholar
• Killock D. Osteoarthritis: Frzb knockout reveals the complexity of Wnt signaling in joint homeostasis. Nat Rev Rheumatol. 2012;8(3):123.
   Google Scholar
• Thysen S, Cailotto F, Luyten FP, Lories RJ. A5.12 SFRPS in cartilage biology: more than just WNT antagonists. Ann Rheum Dis. 2014;73:A67–A68.
   Web of Science ®Google Scholar
• Lories RJ, Corr M, Lane NE. To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol. 2013;9(6):328–339.
   PubMed Web of Science ®Google Scholar
• James IE, Kumar S, Barnes MR, et al. FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosis. Osteoarthritis Cartilage. 2000;8(6):452–463.
   Web of Science ®Google Scholar
• Leijten JC, Emons J, Sticht C, et al. Gremlin 1, frizzled-related protein and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum. 2012;64(10):3302–3312.
   PubMedGoogle Scholar
• Leijten JC, Bos SD, Landman EB, et al. GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors. Arthritis Res Ther. 2013;15(5):R126.
   Web of Science ®Google Scholar
• Ma B, Landman EB, Miclea RL, et al. WNT signaling and cartilage: of mice and men. Calcif Tissue Res. 2013;92(5):399–411.
   Google Scholar
• Garcia-Ibarbia C, Delgado-Calle J, Casafont I, et al. Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders. Gene. 2013;532(2):165–172.
   Web of Science ®Google Scholar
• Loughlin J, Dowling B, Chapman K, et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci U S A. 2004;101(26):9757–9762.
   Web of Science ®Google Scholar
• Lane NE, Lian K, Nevitt MC, et al. Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 2006;54(4):1246–1254.
   Google Scholar
• Rodriguez-Lopez J, Pombo-Suarez M, Liz M, Gomez-Reino JJ, Gonzalez A. Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis. Ann Rheum Dis. 2007;66(8):1052–1055.
   Web of Science ®Google Scholar
• Snelling S, Ferreira A, Loughlin J. Allelic expression analysis suggests that cis-acting polymorphism of FRZB expression does not contribute to osteoarthritis susceptibility. Osteoarthritis Cartilage. 2007;15(1):90–92.
   Web of Science ®Google Scholar
• Valdes AM, Loughlin J, Oene MV, et al. Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum. 2007;56(1):137–146.
   Google Scholar
• Baker-Lepain JC, Lynch JA, Parimi N, et al. Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis. Arthritis Rheum. 2012;64(5):1457–1465.
   PubMedGoogle Scholar
• Velasco J, Zarrabeitia MT, Prieto JR, et al. Wnt pathway genes in osteoporosis and osteoarthritis: differential and genetic association study. Osteoporos Int. 2010;21(1):109–118.
   Web of Science ®Google Scholar
• Lane NE, Nevitt MC, Lui LY, et al. Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum. 2007;56(10):3319–3325.
   PubMed Web of Science ®Google Scholar
• Arrojo E, Drigo R, Bianco AC. Type II deiodinase at the crossroads of thyroid hormone action. Int J Biochem Cell Biol. 2011;43(10):1432–1441.
   PubMed Web of Science ®Google Scholar
• Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev. 2008;29(7):898–938.
   PubMed Web of Science ®Google Scholar
• Cheng AW, Bolognesi M, Kraus VB. DIO2 modifies inflammatory responses in chondrocytes. Osteoarthritis Cartilage. 2012;20(5):440–445.
   Web of Science ®Google Scholar
• Nagase H, Nagasawa Y, Tachida Y, et al. Deiodinase 2 upregulation demonstrated in osteoarthritis patients cartilage causes cartilage destruction in tissue-specific transgenic mice. Osteoarthritis Cartilage. 2013;21(3):514–523.
   Web of Science ®Google Scholar
• Van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration. Osteoarthritis Cartilage. 2012;20(3):223–232.
   PubMed Web of Science ®Google Scholar
• Goldring MB. Insight into the function of DIO2, a susceptibility gene in human osteoarthritis, as an inducer of cartilage damage in a rat model: Is there a role for chondrocyte hypertrophy? Osteoarthritis Cartilage. 2013;21(5):643–645.
   Google Scholar
• Brew CJ, Clegg PD, Boot-Handford RP, Andrew JG, Hardingham T. Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann Rheum Dis. 2010;69(1):234–240.
   PubMed Web of Science ®Google Scholar
• Meulenbelt I, Min JL, Bos S, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Human Mol Genet. 2008;17(12):1867–1875.
   PubMed Web of Science ®Google Scholar
• Bos SD, Bovée JV, Duijnisveld BJ, et al. Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human joint tissues. Ann Rheum Dis. 2012;71(7):1254–1258.
   Web of Science ®Google Scholar
• Rodriguez-Fontenla C, Calaza M, Evangelou E, et al. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheum. 2014;66(4):940–949.
   PubMed Web of Science ®Google Scholar
• Valdes AM, Spector TD. The clinical relevance of genetic susceptibility to osteoarthritis. Best Pract Res Clin Rheumatol. 2010;24(1):3–14.
   PubMed Web of Science ®Google Scholar
• Foussard H, Ferrer P, Valenti P, Polesello C, Carreno S, Payne F. LRCH proteins: a novel family of cytoskeletal regulators. PLoS One. 2010;5(8):e12257.
   Web of Science ®Google Scholar
• Spector TD, Reneland RH, Mah S, et al. Association between a variation in LRCH1 and knee osteoarthritis: a genome-wide single-nucleotide polymorphism association study using DNA pooling. Arthritis Rheum. 2006;54(2):524–532.
   Google Scholar